Evidence map›Paper›PMID 33674554›Full record

ArticleCell death & disease2021

Surgical procedures suppress autophagic flux in the kidney.

Carolyn N Brown, Daniel Atwood, Deepak Pokhrel, Sara J Holditch, Christopher Altmann, Nataliya I Skrypnyk, Jennifer Bourne, Jelena Klawitter, Judith Blaine, Sarah Faubel and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. eLife · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Autophagy in major human diseases.The EMBO journal · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Carolyn N BrownDivision of Renal Diseases and Hypertension, University of Colorado at Denver, Aurora, CO, USA.
Daniel AtwoodDivision of Renal Diseases and Hypertension, University of Colorado at Denver, Aurora, CO, USA.
Deepak PokhrelDivision of Renal Diseases and Hypertension, University of Colorado at Denver, Aurora, CO, USA.
Sara J HolditchDivision of Renal Diseases and Hypertension, University of Colorado at Denver, Aurora, CO, USA.
Christopher AltmannDivision of Renal Diseases and Hypertension, University of Colorado at Denver, Aurora, CO, USA.
Nataliya I SkrypnykDivision of Renal Diseases and Hypertension, University of Colorado at Denver, Aurora, CO, USA.
Jennifer BourneElectron Microscopy Center, University of Colorado at Denver, Aurora, CO, USA.
Jelena KlawitterDivision of Renal Diseases and Hypertension, University of Colorado at Denver, Aurora, CO, USA.
Judith BlaineDivision of Renal Diseases and Hypertension, University of Colorado at Denver, Aurora, CO, USA.
Sarah FaubelDivision of Renal Diseases and Hypertension, University of Colorado at Denver, Aurora, CO, USA.
Andrew ThorburnDepartment of Pharmacology, University of Colorado at Denver, Aurora, CO, USA.
Charles L EdelsteinDivision of Renal Diseases and Hypertension, University of Colorado at Denver, Aurora, CO, USA. Charles.edelstein@cuanschutz.edu.
University of Colorado Denver · US

Funding

PREDOCTORAL TRAINING PROGRAM IN PHARMACOLOGYT32GM007635 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI DELL'ACQUA, MARK L · 1985 to 2023
$6.1M
mTORC1/2 Signaling in the Heart in Autosomal Dominant Polycystic Kidney Disease (ADPKD)I01BX003803 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI CHARLES Louis EDELSTEIN · 2018 to 2026
–
BLRD VA I01 BX003803NIGMS NIH HHS T32 GM007635
6 · The paper itself

Abstract

Many surgical models are used to study kidney and other diseases in mice, yet the effects of the surgical procedure itself on the kidney and other tissues have not been elucidated. In the present study, we found that both sham surgery and unilateral nephrectomy (UNX), which is used as a model of renal compensatory hypertrophy, in mice resulted in increased mammalian target of rapamycin complex 1/2 (mTORC1/2) in the remaining kidney. mTORC1 is known to regulate lysosomal biogenesis and autophagy. Genes associated with lysosomal biogenesis and function were decreased in sham surgery and UNX kidneys. In both sham surgery and UNX, there was suppressed autophagic flux in the kidney as indicated by the lack of an increase in LC3-II or autophagosomes seen on immunoblot, IF and EM after bafilomycin A1 administration and a concomitant increase in p62, a marker of autophagic cargo. There was a massive increase in pro-inflammatory cytokines, which are known to activate ERK1/2, in the serum after sham surgery and UNX. There was a large increase in ERK1/2 in sham surgery and UNX kidneys, which was blocked by the MEK1/2 inhibitor, trametinib. Trametinib also resulted in a significant decrease in p62. In summary, there was an intense systemic inflammatory response, an ERK-mediated increase in p62 and suppressed autophagic flux in the kidney after sham surgery and UNX. It is important that researchers are aware that changes in systemic pro-inflammatory cytokines, ERK1/2 and autophagy can be caused by sham surgery as well as the kidney injury/disease itself.

Indexed as

AutophagyAnimalsAutophagy-Related ProteinsCell LineCytokinesDisease Models, AnimalExtracellular Signal-Regulated MAP KinasesHumansInflammation MediatorsKidneyKidney DiseasesLysosomesMaleMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2MetabolomicsAutophagy-Related ProteinsCytokinesExtracellular Signal-Regulated MAP KinasesInflammation MediatorsMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2

Identifiers

PMID33674554
PMCPMC7935862
OpenAlexW3134178942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.